* Companies to advance development of high-value integrated diagnostics for cardiovascular disease
* GE Healthymagination Fund invests $5 million to drive innovation and new product development
GE Healthcare, the healthcare business of GE (NYSE: GE), and CardioDx, a pioneer in cardiovascular genomic diagnostics, announced that the companies have entered into a strategic alliance to advance and co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease.